Brief: Hybrigenics receives patent for ubiquitin-specific prosthesis

Aton SA

05/09/2014 08:14

Sept 5 (Reuters) - Hybrigenics SA  ALHYG.PA : 
    * Said on Thursday that it has received a patent from 
European Patent Office covering the fourth chemical family 
inhibitors of ubiquitin-specific prosthesis 
    * Said it has received extension of 3 years of the life of 
patent for its first family of USP inhibitors in the United 
States: until mid 2029 instead of mid 2026 
     
 Source text: http://bit.ly/1rbLSOC 
     
 Further company coverage:  ALHYG.PA   
    
    ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920)) 
 
 
Keywords: HYBRIGENICS/BRIEF